Civic Intelligence

National Certification Board for Antiacoagulation Providers

990EZ • Fiscal year 2021 • EIN 16-1768897

Jan 01, 2021 to Dec 31, 2021 • Filed on Feb 02, 2022

Organization Profilewww.ncbap.org/index.aspx
2111 Chestnut Avenue 145Glenview, IL 60025

(837) 983-3519

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2021

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2021

Net Margin

62nd percentile

15%

Higher net margin than 62% of similar nonprofits.

2021 filings • 501(c)6 • <$500k nonprofits • Source year 2021

Top Officer Pay

72nd percentile

$0

Higher top officer pay than 72% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2021 filings • 501(c)6 • <$500k nonprofits • Source year 2021

Asset Growth

55th percentile

10%

Faster asset growth than 55% of similar nonprofits.

2021 filings • 501(c)6 • <$500k nonprofits • Annualized from 2020 to 2021

Revenue Growth

80th percentile

45%

Faster revenue growth than 80% of similar nonprofits.

2021 filings • 501(c)6 • <$500k nonprofits • Annualized from 2020 to 2021

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Up

$70,334

Up $6,539 (+10%) from 2020

Net Assets

Up

$70,334

Up $6,539 (+10%) from 2020

Liabilities

-

No earlier filing loaded for comparison.

Revenue And Expenses
Liabilities / RevenueScore unavailableNet Margin62nd percentile

Revenue

Up

$43,200

Up $13,458 (+45%) from 2020

Expenses

Down

$36,661

Down $18,030 (-33%) from 2020

Net Income

Up

$6,539

Up $31,488 (+126%) from 2020

Historical Trend

Balance Sheet Trend

Asset Growth55th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$150K$100K$50K$0Assets 2011: $60,470Liabilities 2011: $02011Assets 2012: $76,402Liabilities 2012: $02012Assets 2013: $69,701Liabilities 2013: $02013Assets 2014: $86,236Net Assets 2014: $86,2362014Assets 2015: $87,432Net Assets 2015: $87,4322015Assets 2016: $74,305Net Assets 2016: $74,3052016Assets 2017: $70,801Net Assets 2017: $70,8012017Assets 2018: $103,061Liabilities 2018: $02018Assets 2019: $88,744Net Assets 2019: $88,7442019Assets 2020: $63,795Net Assets 2020: $63,7952020Assets 2021: $70,334Net Assets 2021: $70,3342021Assets 2022: $77,355Net Assets 2022: $77,3552022Assets 2023: $99,355Liabilities 2023: $02023Assets 2025: $103,334Net Assets 2025: $103,3342025

Highlighted filing

2021

Assets$70,334
Liabilities-
Net Assets$70,334
Open 2021 Filing

Operations Trend

Revenue Growth80th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100K$50K$0-$50KRevenue 2011: $36,100Expenses 2011: $45,453Net Income 2011: -$9,3532011Revenue 2012: $53,800Expenses 2012: $37,868Net Income 2012: $15,9322012Revenue 2013: $56,100Expenses 2013: $62,801Net Income 2013: -$6,7012013Revenue 2014: $58,000Expenses 2014: $41,465Net Income 2014: $16,5352014Revenue 2015: $59,889Expenses 2015: $58,693Net Income 2015: $1,1962015Revenue 2016: $46,200Expenses 2016: $59,327Net Income 2016: -$13,1272016Revenue 2017: $58,400Expenses 2017: $61,904Net Income 2017: -$3,5042017Revenue 2018: $77,800Expenses 2018: $45,540Net Income 2018: $32,2602018Revenue 2019: $58,156Expenses 2019: $45,659Net Income 2019: $12,4972019Revenue 2020: $29,742Expenses 2020: $54,691Net Income 2020: -$24,9492020Revenue 2021: $43,200Expenses 2021: $36,661Net Income 2021: $6,5392021Revenue 2022: $42,000Expenses 2022: $34,979Net Income 2022: $7,0212022Revenue 2023: $60,788Expenses 2023: $38,788Net Income 2023: $22,0002023Revenue 2025: $26,100Expenses 2025: $38,685Net Income 2025: -$12,5852025

Highlighted filing

2021

Revenue$43,200
Expenses$36,661
Net Income$6,539
Open 2021 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
Feb 2, 2022
Return Version
2021v4.0
Gross Receipts
$43,200
Mission and Program Overview

Mission

Improve the quality of patient care through recognition and promotion of specialized knowledge and skills pertaining to antithrombotic therapy.

Program Services

DescriptionGrantsExpenses
Provided an updated online examination platform to evaluate the applicants' knowledge and skill to manage anticoagulation therapy. This provides a framework to validate achievement of advanced knowledge and skills related to antithrombotic therapy and affords opportunity for professional recognition. During 2021, a total of 111 candidates passed the examination.$28,821-
Compensation and Service Providers
Top Officer Pay72nd percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Janet Campbell RN BSNBoard Member-$0--
Allison Burnett PharmDBoard Member-$0--
Pam Burgwinkle NPBoard Member-$0--
Margaret Fang MDBoard Member-$0--
Gregory D Krol MD FACPBoard Member-$0--
Lynn Oertel ANPPast President-$0--
Susan O'Neill MSN FNPTreasurer-$0--
Kelly Rudd PharmDPresident-$0--
Craig Beavers PharmDBoard Member-$0--
Filing and Contact Details

Filer

Filer Name
National Certification Board for
EIN
16-1768897
Phone
8379833519
Address
2111 Chestnut Avenue 145, Glenview, IL 60025

Signing Officer

Name
Kelly Rudd PharmD
Title
President
Signed
2022-02-02
Discuss with paid preparer
Yes

Preparer

Firm
R L Kearns CPA
Address
3120 Kentish Town Lane, Raleigh, NC 27612
Preparer
Richard L Kearns CPA
Phone
9194280225
Supplemental Narrative

Additional Explanations

Other Expenses.1003

“Information Technology $2500”

Other Expenses.1012

“Insurance $1486”

Other Expenses.1

“Bank/credit card fees $1321”

Raw XML Appendix134 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0Adam Kohm
IRS990EZ/BooksInCareOfDetail/PhoneNum08379833519
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt02111 Chestnut Avenue
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Glenview
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0IL
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd060025
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt063795
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt070334
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/ExcessOrDeficitForYearAmt06539
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt031100
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt063795
IRS990EZ/Form990TotalAssetsGrp/EOYAmt070334
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt043200
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt063795
IRS990EZ/NetAssetsOrFundBalancesEOYAmt070334
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt063795
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt070334
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt00.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt72.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt80.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Janet Campbell RN BSN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Allison Burnett PharmD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Pam Burgwinkle NP
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Margaret Fang MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Gregory D Krol MD FACP
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5Lynn Oertel ANP
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6Susan O'Neill MSN FNP
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7Kelly Rudd PharmD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm8Craig Beavers PharmD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Board Member
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Board Member
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Board Member
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Board Member
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Board Member
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5Past President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt8Board Member
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501cInd0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt05307
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0Improve the quality of patient care through recognition and promotion of specialized knowledge and skills pertaining to antithrombotic therapy.
IRS990EZ/PrintingPublicationsPostageAmt0254
IRS990EZ/ProgramServiceRevenueAmt043200
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Provided an updated online examination platform to evaluate the applicants' knowledge and skill to manage anticoagulation therapy. This provides a framework to validate achievement of advanced knowledge and skills related to antithrombotic therapy and affords opportunity for professional recognition. During 2021, a total of 111 candidates passed the examination.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt028821
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt036661
IRS990EZ/TotalProgramServiceExpensesAmt028821
IRS990EZ/TotalRevenueAmt043200
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0https://www.ncbap.org/index.aspx
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Information Technology $2500
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Insurance $1486
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Bank/credit card fees $1321
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1003
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Expenses.1012
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/FederatedAssuranceLevelCd0FAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd02
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0Kelly Rudd PharmD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/SignatureDt02022-02-02
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0National Certification Board for
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0Antiacoagulation Providers
ReturnHeader/Filer/BusinessNameControlTxt0NATI
ReturnHeader/Filer/EIN0161768897
ReturnHeader/Filer/PhoneNum08379833519
ReturnHeader/Filer/USAddress/AddressLine1Txt02111 Chestnut Avenue 145
ReturnHeader/Filer/USAddress/CityNm0Glenview
ReturnHeader/Filer/USAddress/StateAbbreviationCd0IL
ReturnHeader/Filer/USAddress/ZIPCd060025
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0R L KEARNS CPA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt03120 Kentish Town Lane
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Raleigh
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd027612
ReturnHeader/PreparerPersonGrp/PhoneNum09194280225
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0Richard L Kearns CPA
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02022-02-02T15:56:30-08:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0Kelly Rudd
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0PharmD
ReturnHeader/TaxPeriodBeginDt02021-01-01
ReturnHeader/TaxPeriodEndDt02021-12-31
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2021 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$70,334
Liabilities
-
Net assets
$70,334
Revenue
$43,200
Expenses
$36,661
Net income
$6,539
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$1.03$1.03$0.26$0.39$0.13
2023Summary only. Only limited summary data is available for this year.$0.99$0.00$0.61$0.39$0.22
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.77$0.77$0.42$0.35$0.07
2021Detailed filing. Detailed filing data is available for this year.$0.70$0.70$0.43$0.37$0.07
2020Detailed filing. Detailed filing data is available for this year.$0.64$0.64$0.30$0.55$0.25
2019Detailed filing. Detailed filing data is available for this year.$0.89$0.89$0.58$0.46$0.12
2018Summary only. Only limited summary data is available for this year.$1.03$0.00$0.78$0.46$0.32
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.71$0.71$0.58$0.62$0.04
2016Detailed filing. Detailed filing data is available for this year.$0.74$0.74$0.46$0.59$0.13
2015Detailed filing. Detailed filing data is available for this year.$0.87$0.87$0.60$0.59$0.01
2014Detailed filing. Detailed filing data is available for this year.$0.86$0.86$0.58$0.41$0.17
2013Summary only. Only limited summary data is available for this year.$0.70$0.00$0.56$0.63$0.07
2012Summary only. Only limited summary data is available for this year.$0.76$0.00$0.54$0.38$0.16
2011Summary only. Only limited summary data is available for this year.$0.60$0.00$0.36$0.45$0.09